Australian biotech giant Microba\nhas made an alliance with Macrogen to develop microbiome research services for\nthe offshore market. An MOU has got signed at the Macrogen Headquarters in\nSeoul on 14 March 2019 defining all the partnership terms and condition.\nThrough this MOU, Macrogen and Microba will establish a close cooperation\nsystem. With this partnership, they will try to penetrate into the microbiome\nmarket of Korea and other nations<\/p>\n\n\n\n
Macrogen is a significant Korean\ncompany which has a market capitalization of 350m USD and annual revenues\ntouching 100m USD. The Chairman and Founder Dr. Seo is an eminent scientist. On\nthe other part, Microba is a globally known genomics company with exclusive\ntechnology platform using shotgun metagenomics sequencing to accurately\ncharacterize the millions of micro-organisms that inhabit the large intestine\nknown as the gut genome.<\/p>\n\n\n\n
\u201cMicroba is a company with\nworld-leading technology in the microbiome field, which is one of the\nfastest-growing industries,\u201d<\/em> says Kap-Seok Yang,\nCEO of Macrogen, adding \u201cPartnership between our companies will generate great\nsynergy to develop and launch highly reliable services to global markets such as\nthe USA, Europe, Japan, and Singapore, starting from the Korean market.<\/p>\n\n\n\n On the other hand, Blake Wills,\nCEO of Microba has also expressed his pleasure to work with Macrogen. He has\nalso said that Macrogen is a well-known company for its world-class genetics\nanalysis capacity and its vast experience in data analysis. He is also hopeful\nthat both the companies will work closely to advance microbiome analysis\ntechnology as well as launching various services in the Direct to Consumer,\nResearch and Clinical markets.<\/p>\n","protected":false},"excerpt":{"rendered":" Australian biotech giant Microba has made an alliance with Macrogen to develop microbiome research services for the offshore market. An MOU has got signed at the Macrogen Headquarters in Seoul on 14 March 2019 defining all the partnership terms and condition. Through this MOU, Macrogen and Microba will establish a close cooperation system. With this partnership, they will try to penetrate into the microbiome market of Korea and other nations Macrogen is a significant Korean company which has a market capitalization of 350m USD and annual revenues touching 100m USD….<\/p>\n","protected":false},"author":2,"featured_media":317,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3,5,2],"tags":[114,113,115],"_links":{"self":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts\/316"}],"collection":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/comments?post=316"}],"version-history":[{"count":1,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts\/316\/revisions"}],"predecessor-version":[{"id":318,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/posts\/316\/revisions\/318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/media\/317"}],"wp:attachment":[{"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/media?parent=316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/categories?post=316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blog\/wp-json\/wp\/v2\/tags?post=316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}